von Willebrand factor and its relevance to cardiovascular disorders.
- 1 December 1995
- Vol. 74 (6) , 580-583
- https://doi.org/10.1136/hrt.74.6.580
Abstract
In the past decade the importance of the vascular endothelium in cardiovascular pathophysiology has become more apparent. One substance that is synthesised by and stored in endothelial cells is von Willebrand factor (vWF). When released, vWF seems to mediate platelet aggregation and adhesion to the vascular endothelium. Because the release of vWF is increased when endothelial cells are damaged, vWF has been proposed as an indicator of endothelial disturbance or dysfunction. The availability of such an index of endothelial dysfunction may have clinical value, because measurement of such a marker can be a non-invasive way of assisting in diagnosis or as an indicator of disease progression. The known association between vWF, thrombogenesis, and atherosclerotic vascular disease also suggests that high concentrations of vWF may be an indirect indicator of atherosclerosis and/or thrombosis. In addition, high vWF concentrations have prognostic implications in patients with ischaemic heart disease and peripheral vascular disease.Keywords
This publication has 26 references indexed in Scilit:
- Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysmsThe American Journal of Cardiology, 1995
- Antioxidants, von Willebrand factor and endothelial cell injury in hypercholesterolaemia and vascular diseaseAtherosclerosis, 1995
- Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery diseaseInternational Journal of Cardiology, 1995
- Microalbuminuria and endothelial dysfunction in essential hypertensionPublished by Elsevier ,1994
- Free radicals, antioxidants, and endothelial cell damage after percutaneous transluminal coronary angioplastyCoronary Artery Disease, 1993
- Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart diseaseThe Lancet, 1993
- The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- The endothelium. Target and promoter of hypertension?Hypertension, 1990
- Platelet function tests in thrombotic cerebrovascular disorders.Stroke, 1983
- FACTOR-VIII COMPLEX AND ENDOTHELIAL DAMAGEThe Lancet, 1975